Arranon (nelarabine) Injection 5mg/mL, 50mL Vials, Rx only, For I.V. Infusion only, GlaxoSmith K...

FDA Recall #D-068-2013 — Class II — October 8, 2012

Recall #D-068-2013 Date: October 8, 2012 Classification: Class II Status: Terminated

Product Description

Arranon (nelarabine) Injection 5mg/mL, 50mL Vials, Rx only, For I.V. Infusion only, GlaxoSmith Kline, Research Triangle Park, NC 27709. Made in England, NDC 0007-4401-06

Reason for Recall

Impurities/Degradation Products: Potential for drug related impurities to exceed the specification limits.

Recalling Firm

GlaxoSmithKline, LLC. — Zebulon, NC

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

1,319 vials

Distribution

Nationwide

Code Information

Lot # C536707 Exp 02/14, C538830 Exp.02/14, C533169 Exp. 02/14

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated